Clinical Trial Update: Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating cilostazol to promote hematoma clearance after intracerebral hemorrhage, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: ICH - Intracerebral Hemorrhage | Phase 2 | Status: RECRUITING